Johnson & Johnson (J&J) has reached a A$300 million ($204.90 million) settlement in two Australian class action suits filed by Shine Lawyers for selling defective pelvic mesh implants to Australian women, the law firm said on Monday.
https://www.pharmalive.com/wp-content/uploads/2022/04/ReutersJnJ4182022.jpg485728Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-09-12 05:45:182022-09-12 10:11:46J&J reaches $205 million settlement in Australian pelvic mesh class action
